These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2804192)

  • 21. Increased temporal lobe glucose use in chronic schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
    Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
    Nybäck H; Nyman H; Blomqvist G; Sjögren I; Stone-Elander S
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):672-8. PubMed ID: 1719135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of PET studies in diagnosis of corticobasal degeneration.
    Lutte I; Laterre C; Bodart JM; De Volder A
    Eur Neurol; 2000; 44(1):12-21. PubMed ID: 10894990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual stimulation increases regional cerebral blood flow and metabolism in the goldfish.
    Altenau LL; Agranoff BW
    Brain Res; 1979 Jan; 161(1):55-61. PubMed ID: 758970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
    Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
    J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
    Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
    [No Abstract]   [Full Text] [Related]  

  • 27. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia.
    Buchsbaum MS
    Schizophr Bull; 1990; 16(3):379-89. PubMed ID: 2287929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
    Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
    Acta Psychiatr Scand; 1987 Dec; 76(6):628-41. PubMed ID: 3502060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
    Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic changes accompanying denervation and reinnervation of the dentate gyrus of the rat measured by [3H]2-deoxyglucose autoradiography.
    Steward O; Smith LK
    Exp Neurol; 1980 Sep; 69(3):513-27. PubMed ID: 7409062
    [No Abstract]   [Full Text] [Related]  

  • 31. PET in relation to intracranial electrode evaluations.
    Engel J; Henry TR; Risinger MW; Sutherling WW; Chugani HT
    Epilepsy Res Suppl; 1992; 5():111-20. PubMed ID: 1418439
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic effects of lithium in schizophrenia.
    Alexander PE; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 Mar; 136(3):283-7. PubMed ID: 369396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study.
    Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):463-7. PubMed ID: 21220791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal ganglia infarction demonstrated by radionuclide brain imaging.
    Kim EE; Schacht RA; Domstad PA; DeLand FH
    Clin Nucl Med; 1982 Nov; 7(11):512-5. PubMed ID: 6756740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain mediation of Anolis social dominance displays. I. Differential basal ganglia activation.
    Baxter LR; Ackermann RF; Clark EC; Baxter JE
    Brain Behav Evol; 2001 Apr; 57(4):169-83. PubMed ID: 11641556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergism of combined lithium-neuroleptic therapy: a double-blind, placebo-controlled case study.
    Bigelow LB; Weinberger DR; Wyatt RJ
    Am J Psychiatry; 1981 Jan; 138(1):81-3. PubMed ID: 7192495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals.
    Buchsbaum MS; Holcomb HH; Johnson J; King AC; Kessler R
    Hum Neurobiol; 1983; 2(1):35-8. PubMed ID: 6603452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of increased metabolic activity in somatosensory cortex of monkeys Macaca fascicularis, subjected to controlled cutaneous stimulation: a 2-deoxyglucose study.
    Juliano SL; Hand PJ; Whitsel BL
    J Neurophysiol; 1981 Dec; 46(6):1260-84. PubMed ID: 6275042
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome.
    Serata D; Rapinesi C; Kotzalidis GD; Alessi MC; Janiri D; Massolo AC; Ferri VR; Criscuolo S; Callovini G; Angeletti G; Girardi P; Del Casale A
    Int J Psychiatry Med; 2015; 50(3):251-6. PubMed ID: 26443711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.